0001214659-23-013090.txt : 20231003 0001214659-23-013090.hdr.sgml : 20231003 20231003170246 ACCESSION NUMBER: 0001214659-23-013090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230905 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAZIMI A J CENTRAL INDEX KEY: 0001075050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 231305105 MAIL ADDRESS: STREET 1: 1207 17TH AVENUE SUITE 103 CITY: NASHVILLE STATE: TN ZIP: 37212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-62743.xml PRIMARY DOCUMENT X0508 4 2023-09-05 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001075050 KAZIMI A J 1600 WEST END AVE. SUITE 1300 NASHVILLE TN 37203 true true true false Chairman and CEO 1 Common Stock 2023-09-05 5 L false E 65 1.68 A 5716965 D Common Stock 2023-09-06 5 L false E 65 1.65 A 5717030 D Common Stock 2023-09-07 5 L false E 65 1.68 A 5717095 D Common Stock 2023-09-08 5 L false E 65 1.68 A 5717160 D Common Stock 2023-09-11 5 L false E 65 1.71 A 5717225 D Common Stock 2023-09-12 5 L false E 65 1.76 A 5717290 D Common Stock 2023-09-13 5 L false E 65 1.83 A 5717355 D Common Stock 2023-09-14 5 L false E 65 1.84 A 5717420 D Common Stock 2023-09-15 5 L false E 23 1.82 A 5717443 D Common Stock 2023-09-18 5 L false E 55 2.03 A 5717498 D Common Stock 2023-09-19 5 L false E 55 2.12 A 5717553 D Common Stock 2023-09-20 5 L false E 55 2.14 A 5717608 D Common Stock 2023-09-21 5 L false E 55 2.28 A 5717663 D Common Stock 2023-09-22 5 L false E 55 2.29 A 5717718 D Common Stock 2023-09-25 5 L false E 55 2.24 A 5717773 D Common Stock 2023-09-26 5 L false E 55 2.07 A 5717828 D Common Stock 2023-09-27 5 L false E 55 1.98 A 5717883 D Common Stock 2023-09-28 5 L false E 55 1.96 A 5717938 D Common Stock 2023-09-29 5 L false E 55 1.90 A 5717993 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. A.J. Kazimi by /s/ John Hamm as attorney-in-fact 2023-10-03